Automatic issuing system of clopidogrel medication related gene test reports

A clopidogrel and genetic testing technology, applied in the field of medical information management, can solve problems such as error-prone, weakened ability, time-consuming and labor-intensive, etc., and achieve the effect of reducing the incidence of errors, saving time and cost, and avoiding manpower

Active Publication Date: 2018-10-30
SHANGHAI CONLIGHT MEDICAL LTD
View PDF6 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology allows healthcare professionals to easily send out their own personalized medicine advice without having them manually input everything from patients with specific conditions such as blood pressure levels that may affect how well they treat people who have high cholesterol level symptoms. By integrally compiling all these data into one program, this method saves considerable effort while also providing accurate insights about each person's condition at once.

Problems solved by technology

Technological Problem addressed in this patents relates to improving the efficiency and accuracy of identifying specific genes involved with drugs used specifically against clavulocyte growth factor receptor 1/cadilyside transporters associated with diseases such as chronic idiopathy renal disease. Current methods involve manual analysis involving multiple tests, leading to increased workload and potential sources of bias due to subjective interpretation. Additionally, they require significant resources from both the manufacturer side and the hospital side.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Automatic issuing system of clopidogrel medication related gene test reports
  • Automatic issuing system of clopidogrel medication related gene test reports
  • Automatic issuing system of clopidogrel medication related gene test reports

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0098] Such as figure 1 As shown, Embodiment 1 of the present invention provides a system for automatically issuing a gene detection report related to clopidogrel medication, including the following parts:

[0099] The basic information management module 1 is used to sort out and store the basic clinical data of patients and the detection results of genes related to clopidogrel medication. The genes related to clopidogrel medication include CYP2C19 gene, PON1 gene and ABCB1 gene. The CYP2C19 Genes include CYP2C19*2 locus, CYP2C19*3 locus and CYP2C19*17 locus, among which CYP2C19*2 locus, CYP2C19*3 locus and PON1 gene all include GG, GA, AA three genotypes, CYP2C19*17 Both the site and the ABCB1 gene include CC, CT, and TT genotypes;

[0100] The basic clinical information of the patient can be entered manually or exported from the hospital's office system, including medical record number, name, gender, age, ethnicity, height, weight, department, bed number, sending physician,...

Embodiment 2

[0107] Such as figure 2 As shown, on the basis of Example 1, this Example 2 provides a system for automatically issuing a clopidogrel drug-related gene detection report. This Example 2 further defines that the basic information management module 1 includes the following parts:

[0108] The communication unit 11 is used to obtain the patient's case information and gene detection information from the hospital information system;

[0109] The related systems of hospital registration information include HIS system (Hospital Information System, hospital information system), LIS system (Laboratory Information System, laboratory information system), etc. The relevant information of patients can be directly retrieved and copied from the above systems, so that There is no need for manual entry when issuing the test report;

[0110] A basic clinical data entry unit 12, configured to extract and store basic clinical information from the case information;

[0111] The gene detection re...

Embodiment 3

[0115] Such as image 3 As shown, this embodiment 3 provides a system for automatically issuing a clopidogrel drug-related gene detection report on the basis of embodiment 1. This embodiment 3 further defines that the detection conclusion derivation module 2 includes the following parts:

[0116] The gene type judging unit 21 is used to judge the gene types of the patient's CYP2C19 gene, PON1 gene, and ABCB1 gene according to the detection results of clopidogrel-related genes;

[0117] CYP2C19 enzyme is closely related to whether resistance reaction occurs after clopidogrel administration; PON1 enzyme also plays a key role in the process of converting clopidogrel into active product, but its role is not as prominent as CYP2C19 enzyme; Plays a role in intestinal absorption into the blood, but is weaker than the PON1 enzyme. Therefore, it is necessary to judge the genotypes of the above three genes separately, so that the subsequent detection conclusion can be drawn by integrat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an automatic issuing system of clopidogrel medication related gene test reports. Each test report contains much information like basic information of a patient, test result, test conclusion and personalized medication suggestion, the system can effectively integrate and display the much information in a centralized manner, and the personalized medication suggestion portion can be directly applied mechanically after being edited in a unified manner and can be added with personalized remark information; the test reports can be issued quickly, efficiently and accurately according to results of genotype of related genes (CYP 2C19, PON1 and ABCB1 genes) on a gene testing instrument even if there are many testing cases, and the system can automatically issue the test reports as long as the patients input basic clinical information and gene testing results. Consumption of a lot of manpower when issuing troublesome reports is avoided, a lot of time cost can be saved, anderror rate during report issuing can be lowered, so that the system is convenient for medical staff to use in clinical work.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SHANGHAI CONLIGHT MEDICAL LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products